---
schema_version: "secwatch.filing_event.v1"
accession: "0001171843-25-000190"
form_type: "8-K"
ticker: "BCRX"
cik: "0000882796"
company_name: "BIOCRYST PHARMACEUTICALS INC"
filed_at: "2025-01-13T23:59:59+00:00"
generated_at: "2026-05-28T04:19:29.356308+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.0
calibrated_materiality_score: 0.0
confidence: "high"
source: SEC EDGAR
---

# BioCryst to present at J.P. Morgan Healthcare Conference on Jan 14; slides posted Jan 13

## Summary
- Presentation at 43rd Annual J.P. Morgan Healthcare Conference in San Francisco on Jan 14 at 6:00 p.m. ET.
- Slides covering drug discovery and development programs posted Jan 13 on BioCryst IR website.
- No new financial or business updates disclosed in the filing.

## SEC filing metadata
- accession: 0001171843-25-000190
- form_type: 8-K
- ticker: BCRX
- cik: 0000882796
- company_name: BIOCRYST PHARMACEUTICALS INC
- filed_at: 2025-01-13T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.0
- calibrated_materiality_score: 0.0
- confidence: high
- sec_items: 7.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/882796/000117184325000190/0001171843-25-000190-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/882796/000117184325000190/f8k_011325.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001171843-25-000190
- JSON: https://secwatch.observer/filing/0001171843-25-000190.json
- Plain text: https://secwatch.observer/filing/0001171843-25-000190.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.